InMed Pharmaceuticals Inc. (INM)
NASDAQ: INM · IEX Real-Time Price · USD
0.269
+0.013 (5.00%)
Jul 22, 2024, 10:15 AM EDT - Market open
InMed Pharmaceuticals Employees
InMed Pharmaceuticals had 13 employees as of June 30, 2023. The number of employees did not change compared to the previous year.
Employees
13
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$432,748
Profits / Employee
-$467,405
Market Cap
2.34M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
cbdMD | 52 |
NovaBay Pharmaceuticals | 26 |
Tenon Medical | 21 |
Catheter Precision | 14 |
Cyclacel Pharmaceuticals | 12 |
Heart Test Laboratories | 12 |
Phio Pharmaceuticals | 9 |
Tivic Health Systems | 9 |
INM News
- 5 weeks ago - InMed to Present at the Emerging Growth Conference - Newsfile Corp
- 2 months ago - InMed Pharmaceuticals Reports Third Quarter Fiscal 2024 Financial Results and Provides Business Update - Newsfile Corp
- 3 months ago - InMed Appoints Dr. David G. Morgan, PhD, a Leading Alzheimer's Expert, to the Company's Scientific Advisory Board - Newsfile Corp
- 3 months ago - InMed Provides Update on INM-089 in the Treatment of Dry Age-Related Macular Degeneration - Newsfile Corp
- 3 months ago - InMed's INM-901 Demonstrates Favorable Pharmacological and Behavioral Effects in In Vivo Preclinical Alzheimer's Disease Studies - Newsfile Corp
- 4 months ago - InMed Granted 180-Day Extension to Achieve Nasdaq Minimum Bid Compliance - Newsfile Corp
- 5 months ago - InMed Reports Second Fiscal Quarter 2024 Financial Results and Provides Business Update - Newsfile Corp
- 5 months ago - InMed Pharmaceuticals Strengthens Executive Leadership Team with Appointment of Ms. Netta Jagpal as Chief Financial Officer - Newsfile Corp